Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The functional importance of VCP to maintaining cellular protein homeostasis. | Biochem Soc Trans | 2022 | 36196920 | PubTator, text mining | PubMed |
| Retinitis Pigmentosa in the Puerto Rican Population: A Geographic Distribution. | Clin Ophthalmol | 2022 | 36196406 | PubTator, text mining | PubMed |
| Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma. | Front Genet | 2022 | 36186418 | PubTator, text mining | PubMed |
| Retinal organoids and microfluidic chip-based approaches to explore the retinitis pigmentosa with USH2A mutations. | Front Bioeng Biotechnol | 2022 | 36185441 | PubTator, text mining | PubMed |
| Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments. | J Transl Med | 2022 | 36180956 | PubTator, text mining | PubMed |
| Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas. | Sci Rep | 2022 | 36175606 | PubTator, text mining | PubMed |
| Eyes on CHARGE syndrome: Roles of CHD7 in ocular development. | Front Cell Dev Biol | 2022 | 36172288 | PubTator, text mining | PubMed |
| Establishment, immunological analysis, and drug prediction of a prognostic signature of ovarian cancer related to histone acetylation. | Front Pharmacol | 2022 | 36172179 | PubTator, text mining | PubMed |
| Outcomes of Gene Panel Testing for Sensorineural Hearing Loss in a Diverse Patient Cohort. | JAMA Netw Open | 2022 | 36166228 | PubTator, text mining | PubMed |
| RPE65 c.353G>A, p.(Arg118Lys): A Novel Point Mutation Associated with Retinitis Pigmentosa and Macular Atrophy | Int J Mol Sci | 2022 | 36142423 | PubTator, text mining | PubMed |
| Exome Sequencing Identified Molecular Determinants of Retinal Dystrophies in Nine Consanguineous Pakistani Families. | Genes (Basel) | 2022 | 36140798 | PubTator, text mining | PubMed |
| The Effects of Oncolytic Pseudorabies Virus Vaccine Strain Inhibited the Growth of Colorectal Cancer HCT-8 Cells In Vitro and In Vivo. | Animals (Basel) | 2022 | 36139276 | PubTator, text mining | PubMed |
| Comprehensive evaluation of the safety and immunogenicity of a gene-deleted variant pseudorabies virus attenuated vaccine. | Vet Res | 2022 | 36138470 | PubTator, text mining | PubMed |
| GenOtoScope: Towards automating ACMG classification of variants associated with congenital hearing loss. | PLoS Comput Biol | 2022 | 36129964 | PubTator, text mining | PubMed |
| Genetic Characteristics and Variation Spectrum of USH2A-Related Retinitis Pigmentosa and Usher Syndrome. | Front Genet | 2022 | 36110214 | PubTator, text mining | PubMed |
| Identification of m6A modification patterns and development of m6A-hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer. | Front Immunol | 2022 | 36105819 | PubTator, text mining | PubMed |
| O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy. | Mol Med | 2022 | 36104770 | PubTator, text mining | PubMed |
| A novel pyroptosis related genes signature for predicting prognosis and estimating tumor immune microenvironment in lung adenocarcinoma. | Transl Cancer Res | 2022 | 36093538 | PubTator, text mining | PubMed |
| Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma. | Front Immunol | 2022 | 36091041 | PubTator, text mining | PubMed |
| Long-read sequencing for molecular diagnostics in constitutional genetic disorders. | Hum Mutat | 2022 | 36086952 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=30